We help Pharmaceutical Fraud Whistleblowers

Pharma Whistle Blower Blog



Pharm D Solutions (Houston TX) Recalls All Sterile Products

Pharm D Solutions (Houston TX) Recalls All Sterile ProductsPharm D Solutions LLC is a newcomer to the pharmaceutical industry. FDA records suggest the company has been operating since 2014. The company’s website claims it opened its doors in 2015.
Pharm D Solutions operates as a national compounding pharmacy. According to its marketing...

Oh Woe is Wochardt!

Oh Woe is Wochardt!“Real Breaking News!” India’s leading cGMP offender has now imported their deviant behaviors to its sterile products USA facility! Wochardt has been the subject of huge recalls and import bans by FDA over non-compliance of cGMPs, and now the FDA is apparently quite upset that...



112 Million Deficient Prescriptions Dispensed in the US!

112 Million Deficient Prescriptions Dispensed in the US!On June 14th, The International Journal of Health Services reported that over the last 18 years, 17 different drugs were approved for patient use and later pulled because they were unsafe. That may not sound like much but those 17 prescription drugs were prescribed 112 million times. Nine of these...

Legal & Safety ALERT! Seeking Information on Counterfeit BiCNU

Legal & Safety ALERT! Seeking Information on Counterfeit BiCNUThe U.S. Food and Drug Administration issued an alert for counterfeit BiCNU, an FDA approved cancer drug. Also known as carmustine, BiCNU is an injectable medication used to treat brain cancer, multiple myeloma, and lymphoma (Hodgkin’s and non-Hodgkin’s). Although there is no known...


When Medication Kills – Recall of Pharmakon Morphine Sulfate

When Medication Kills – Recall of Pharmakon Morphine SulfateMistakes happen. We hear stories every week about prescription drugs that are sub-potent or superpotent. Very often the drugs in our medicine cabinets are subpotent meaning they have insufficient Active Pharmaceutical Ingredient (API). Frequently these poor quality drugs are manufactured in India...

Anonymous Whistleblower Uncovers Novartis FCPA Violations in Turkey

Anonymous Whistleblower Uncovers Novartis FCPA Violations in TurkeyWhistleblower remains anonymous for fear of retaliation, allegations are under internal investigation
According to a whistleblower who has chosen to remain anonymous, Swiss drugmaker Novartis bribed government officials in Turkey to obtain advantages that may have translated into $85 million...

“The employee who, in the public interest, has the personal courage to challenge illegality is a kind of public hero.”
© 2020 Pharmaceutical Integrity Coalition